- Active Substance: ACP105
- Concentration: 10 mg/cap
- Pack Size: 90 caps
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: ACP105
SKU: P4052
ACP-105 10mg - Ultima Pharmaceuticals
Explore ACP-105 from Ultima Pharmaceuticals, containing 10mg of ACP105 per capsule. This product, available in a pack of 90 capsules, is categorized under SARMs (Selective Androgen Receptor Modulators) and is often the subject of research for its selective effects on androgen receptors.
Product Details
- Active Substance: Active Substance: ACP105
- Concentration: 10 mg/cap
- Pack Size: 90 caps
- Manufacturer: Ultima Pharmaceuticals
- Brand Name: ACP105
Understanding ACP-105 (ACP105) - A Pharmacological Perspective
ACP-105, developed by Ultima Pharmaceuticals, is a Selective Androgen Receptor Modulator (SARM). SARMs are a class of compounds that bind to androgen receptors in the body. The selectivity of SARMs is a key area of ongoing research, with the aim of eliciting anabolic effects in muscle and bone tissue while minimizing effects on other organs, thereby potentially reducing some of the side effects associated with traditional anabolic steroids.
Mechanism of Action (Pharmacological Overview)
ACP105 is being investigated for its affinity and selectivity for androgen receptors. Preclinical studies suggest it may exhibit a strong anabolic effect with a lower propensity for androgenic side effects compared to non-selective androgens. The precise mechanism involves binding to androgen receptors, leading to gene transcription and protein synthesis in target tissues. Research continues to explore its specific binding profiles and downstream signaling pathways.
Potential Research Benefits (For Research Purposes Only)
- Potential for selective muscle tissue anabolism.
- Investigated for bone density enhancement.
- Research into a potentially improved safety profile compared to traditional anabolic agents.
Please note: The potential benefits listed above are based on ongoing research and have not been fully established in humans. ACP-105 is currently not approved for human therapeutic use by regulatory authorities.
Usage Guidelines (For Research Purposes Only)
As a research compound, any guidelines provided are strictly for laboratory or research settings. Dosages and administration protocols vary significantly depending on the specific research objectives and models being used. Any information regarding human dosage or administration is speculative and not recommended.
Potential Side Effects (Based on Research)
Research on ACP-105 is ongoing, and its full side effect profile in humans is not yet fully understood. Preclinical studies have indicated a potentially lower incidence of some androgenic side effects compared to traditional steroids. However, potential side effects may still include hormonal imbalances and other unforeseen effects. Further research is crucial to fully characterize its safety profile.
FAQ
What is ACP-105?
ACP-105 is a Selective Androgen Receptor Modulator (SARM) developed by Ultima Pharmaceuticals. It is being researched for its selective effects on androgen receptors.
How does ACP-105 work?
ACP-105 binds to androgen receptors in the body. Research suggests it may do so selectively, potentially leading to anabolic effects in muscle and bone with fewer effects on other organs.
What are the potential research benefits of ACP-105?
Potential research benefits include selective muscle tissue anabolism and bone density enhancement. However, these are based on ongoing research and are not established for human therapeutic use.
What are the potential side effects of ACP-105?
The full side effect profile in humans is still under investigation. Preclinical studies suggest a potentially lower incidence of some androgenic effects, but hormonal imbalances and other effects are possible. Further research is needed.
Important Note: ACP-105 is a research compound and is not approved for human therapeutic use by regulatory authorities. Information provided here is for research and informational purposes only. It is not intended as a guide for personal use. The use of SARMs carries potential risks, and their long-term effects are not fully understood. Consult with qualified healthcare professionals for any health concerns.